These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 3917455)

  • 1. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia.
    Bouchard P; Lagoguey M; Brailly S; Schaison G
    J Clin Endocrinol Metab; 1985 Feb; 60(2):258-62. PubMed ID: 3917455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ; Hermanussen M; Sippell WG
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men.
    Aloi JA; Bergendahl M; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 1997 May; 82(5):1543-8. PubMed ID: 9141547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary gonadotropin-releasing hormone (GnRH) receptor responses to GnRH in hypothalamus-lesioned rats: inhibition of responses by hyperprolactinemia and evidence that testosterone and estradiol modulate gonadotropin secretion at postreceptor sites.
    Pieper DR; Gala RR; Schiff MA; Regiani SR; Marshall JC
    Endocrinology; 1984 Sep; 115(3):1190-6. PubMed ID: 6086288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinemia inhibits gonadotropin-releasing hormone (GnRH) stimulation of the number of pituitary GnRH receptors.
    Garcia A; Herbon L; Barkan A; Papavasiliou S; Marshall JC
    Endocrinology; 1985 Sep; 117(3):954-9. PubMed ID: 2990879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
    Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man.
    Gross KM; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1987 Apr; 64(4):675-80. PubMed ID: 3102545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile gonadotropin-releasing hormone treatment in idiopathic delayed puberty.
    Wagner TO; Brabant G; Warsch F; Hesch RD; von zur Mühlen A
    J Clin Endocrinol Metab; 1986 Jan; 62(1):95-101. PubMed ID: 2933423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
    Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadotropic hypogonadism: hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone.
    Valk TW; Corley KP; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1980 Oct; 51(4):730-8. PubMed ID: 6774991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners.
    Veldhuis JD; Evans WS; Demers LM; Thorner MO; Wakat D; Rogol AD
    J Clin Endocrinol Metab; 1985 Sep; 61(3):557-63. PubMed ID: 3926810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.